---
figid: PMC6628025__cells-08-00540-g001
figlink: /pmc/articles/PMC6628025/figure/cells-08-00540-f001/
number: Figure 1
caption: Fibroblast growth factor receptors (FGFRs) are highly conserved transmembrane
  receptors consisting of three extracellular immunoglobulin-like (Ig-like) domains,
  a transmembrane helical region, and a cytoplasmic region with kinase activity. The
  fibroblast growth factor (FGF) ligand and its cofactor heparin sulfate proteoglycan
  (HSPG) bind to FGFR monomers, leading to dimerization and tyrosine cross-autophosphorylation
  of the cytoplasmic domain. This induces various signaling pathways, resulting in
  cellular proliferation, survival, migration, angiogenesis, and cell fate determination
  in embryogenesis and in response to microenvironmental signals, including therapeutics.
  FGF/FGFR signaling can be stimulated in a paracrine manner, mainly in physiological
  settings, or in an autocrine manner as demonstrated in various cancers. In melanoma,
  FGF/FGFR signaling is largely suppressed by mutation-driven enhanced activity of
  the RAS (Rat sarcoma oncogene)/BRAF (v-Raf murine sarcoma viral oncogene homolog
  B)/MEK (mitogen-activated protein kinase)/ERK (extracellular signal-regulated kinase)
  pathway (red framed). Melanoma cells that acquire the ability to secrete FGFs and
  stimulate FGFR in a paracrine or autocrine manner can contribute to angiogenesis
  and cell-fate decisions involving transitions between different phenotypes, including
  phenotypes resistant to targeted therapies (grey framed). Dab, dabrafenib; DUSP,
  dual-specificity phosphatase; FRS2, FGFR substrate 2; GAB1, GRB2-associated binding
  protein 1; GRB2, growth factor receptor protein 2; JAK, Janus kinase; PKC, protein
  kinase C; PLC-γ, phospholipase C gamma; SOS, son of sevenless; SEF, similar expression
  to FGF; SPRY, Sprouty; STAT, signal transducer and activator of transcription; Tra,
  trametinib; Vem, vemurafenib.
pmcid: PMC6628025
papertitle: Fibroblast Growth Factor Receptor Signaling in Skin Cancers.
reftext: Malgorzata Czyz. Cells. 2019 Jun;8(6):540.
pmc_ranked_result_index: '131662'
pathway_score: 0.9415685
filename: cells-08-00540-g001.jpg
figtitle: Fibroblast growth factor receptors (FGFRs) are highly conserved transmembrane
  receptors consisting of three extracellular immunoglobulin-like (Ig-like) domains,
  a transmembrane helical region, and a cytoplasmic region with kinase activity
year: '2019'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6628025__cells-08-00540-g001.html
  '@type': Dataset
  description: Fibroblast growth factor receptors (FGFRs) are highly conserved transmembrane
    receptors consisting of three extracellular immunoglobulin-like (Ig-like) domains,
    a transmembrane helical region, and a cytoplasmic region with kinase activity.
    The fibroblast growth factor (FGF) ligand and its cofactor heparin sulfate proteoglycan
    (HSPG) bind to FGFR monomers, leading to dimerization and tyrosine cross-autophosphorylation
    of the cytoplasmic domain. This induces various signaling pathways, resulting
    in cellular proliferation, survival, migration, angiogenesis, and cell fate determination
    in embryogenesis and in response to microenvironmental signals, including therapeutics.
    FGF/FGFR signaling can be stimulated in a paracrine manner, mainly in physiological
    settings, or in an autocrine manner as demonstrated in various cancers. In melanoma,
    FGF/FGFR signaling is largely suppressed by mutation-driven enhanced activity
    of the RAS (Rat sarcoma oncogene)/BRAF (v-Raf murine sarcoma viral oncogene homolog
    B)/MEK (mitogen-activated protein kinase)/ERK (extracellular signal-regulated
    kinase) pathway (red framed). Melanoma cells that acquire the ability to secrete
    FGFs and stimulate FGFR in a paracrine or autocrine manner can contribute to angiogenesis
    and cell-fate decisions involving transitions between different phenotypes, including
    phenotypes resistant to targeted therapies (grey framed). Dab, dabrafenib; DUSP,
    dual-specificity phosphatase; FRS2, FGFR substrate 2; GAB1, GRB2-associated binding
    protein 1; GRB2, growth factor receptor protein 2; JAK, Janus kinase; PKC, protein
    kinase C; PLC-γ, phospholipase C gamma; SOS, son of sevenless; SEF, similar expression
    to FGF; SPRY, Sprouty; STAT, signal transducer and activator of transcription;
    Tra, trametinib; Vem, vemurafenib.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FGF13
  - FGF11
  - FGF12
  - AKT1
  - AKT2
  - FGF10
  - AKT3
  - MAPK1
  - MAPK3
  - FGF22
  - DUSP6
  - FGF2
  - FGF3
  - FGF4
  - FGF1
  - FGF7
  - FGF8
  - FGF9
  - DUSP5
  - IL17RD
  - SOS1
  - SOS2
  - SPRY3
  - SPRY1
  - FGF14
  - FGF20
  - FGF21
  - FGF5
  - FGF6
  - HRAS
  - KRAS
  - NRAS
  - TRA
  - FRS2
  - GAB1
  - GRB2
  - SDC2
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - DUSP1
  - DUSP2
  - DUSP3
  - DUSP4
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - ARAF
  - RAF1
  - BRAF
  - FGF18
  - FGF17
  - FGF16
  - FGF19
  - STAT6
  - SPRY4
  - STAT1
  - STAT2
  - SPRY2
  - MAP2K2
  - PRKD3
  - PRKCA
  - FGF23
  - MAP2K1
  - STAT3
  - STAT4
  - STAT5B
  - STAT5A
  - Cancer
  - Cardiomyopathy
  - Kallmann syndrome
  - Noonan syndrome
genes:
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF13
  entrez: '2258'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF11
  entrez: '2256'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF12
  entrez: '2257'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF10
  entrez: '2255'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF22
  entrez: '27006'
- word: DUSP
  symbol: DUSP
  source: bioentities_symbol
  hgnc_symbol: DUSP6
  entrez: '1848'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF2
  entrez: '2247'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF3
  entrez: '2248'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF4
  entrez: '2249'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF1
  entrez: '2246'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF7
  entrez: '2252'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF8
  entrez: '2253'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF9
  entrez: '2254'
- word: DUSP
  symbol: DUSP
  source: bioentities_symbol
  hgnc_symbol: DUSP5
  entrez: '1847'
- word: SEF
  symbol: SEF
  source: hgnc_alias_symbol
  hgnc_symbol: IL17RD
  entrez: '54756'
- word: Sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: Sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: SPRY
  symbol: SPRY
  source: bioentities_symbol
  hgnc_symbol: SPRY3
  entrez: '10251'
- word: SPRY
  symbol: SPRY
  source: bioentities_symbol
  hgnc_symbol: SPRY1
  entrez: '10252'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF14
  entrez: '2259'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF20
  entrez: '26281'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF21
  entrez: '26291'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF5
  entrez: '2250'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF6
  entrez: '2251'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: Tra
  symbol: TRA
  source: hgnc_symbol
  hgnc_symbol: TRA
  entrez: '6955'
- word: FRS2
  symbol: FRS2
  source: hgnc_symbol
  hgnc_symbol: FRS2
  entrez: '10818'
- word: GAB1
  symbol: GAB1
  source: hgnc_symbol
  hgnc_symbol: GAB1
  entrez: '2549'
- word: GRB2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: HSPG
  symbol: HSPG
  source: hgnc_prev_symbol
  hgnc_symbol: SDC2
  entrez: '6383'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: DUSP
  symbol: DUSP
  source: bioentities_symbol
  hgnc_symbol: DUSP1
  entrez: '1843'
- word: DUSP
  symbol: DUSP
  source: bioentities_symbol
  hgnc_symbol: DUSP2
  entrez: '1844'
- word: DUSP
  symbol: DUSP
  source: bioentities_symbol
  hgnc_symbol: DUSP3
  entrez: '1845'
- word: DUSP
  symbol: DUSP
  source: bioentities_symbol
  hgnc_symbol: DUSP4
  entrez: '1846'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF18
  entrez: '8817'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF17
  entrez: '8822'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF16
  entrez: '8823'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF19
  entrez: '9965'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: SPRY
  symbol: SPRY
  source: bioentities_symbol
  hgnc_symbol: SPRY4
  entrez: '81848'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: SPRY
  symbol: SPRY
  source: bioentities_symbol
  hgnc_symbol: SPRY2
  entrez: '10253'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF23
  entrez: '8074'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Kallmann syndrome
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
